1Zhong N,Wang C,Yao W,et al. Prevalence of chronic obstructive pulmonary disease in China: a large,population- based survey [J]. Am J Respir Crit Care Med, 2007,176: 753-760.
3Chakrabarti B, Angus RM, Agarwal S, et al. Hyperglycaemia as a pre- dictor of outcome during non- invasive ventilation in decompen- sated COPD [ J ]. Thorax, 2009,64 ( 10 ) : 857 - 863.
4Boscia JA, Pudi KK, Zvarich MT, et al. Effect of once- daily fluticas- one furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized,three-way,in- complete block, crossover study[ J ]. Clin Ther, 2012,34 (8) : 1 655 - 1 666.
5Gunen H,Mirici A,Meral M,et al. Steroids in acute exacerba-tions of chronic obstructive pulmonary disease: are nebulized and systemic forms comparable [ J ] ? Curr Opin Pulm Med, 2009,15 ( 2 ) : 133 - 137.
6Roos AB, Berg T, Nord M. A relationship between epithelial matu- ration,bronchopulmonary dysplasia,and chronic obstructive pul- monary disease [ J ]. Pulm Med, 2012,24:194 - 196.
7Potocka E, Amin N, Cassidy J, et al. Insulin pharmacokinetics follow- i nB dosinB with technosphere insulin in subjects with chronic obstructive pulmonary disease[J]. Curr Med Res Opin,2010,26 (10):2 347-2 353.
8Baker EH, Janaway CH,Philips B J, et al. Hyperglycaemia is associ- ated with poor outcome in patients admitted to hospital with acute ex- acerbations of chronic obstructive pulmonary disease[J]. Thorax, 2006,61 : 284 -289.
9Slatore CG,Bryson CL,Au DH.The association of inhaled corticos- teroid use with serum glucose concentration in a large cohort [ J ].Am J Med, 2009,122(5 ) : 472 -478.
10Becker T, Moldoveanu A, Cukierman T,et al. Clinical outcomes as - sociated with the use of subcutaneous insulin - by - glucose sliding scales to manage hyperglycemia in hospitalized patients with pneumonia[ J ].Diabetes Res Clin Pract, 2007,78 (3) : 392 - 397.
4Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study):a population-based prevalence study. Lancet, 2007, 370: 741- 750.
5Pauwels RA, Buist AS, Calverley PM,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med, 2001,163: 1256-1276.
6Rabe KF, Hurd S, Anzueto A,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med,2007,176:532-555.
7Chapman KR, Bourbeau J, Ranee L. The burden of COPD in Canada: results from the Confronting COPD survey. Respir Med,2003,97 Suppl C:S23-S31.
8Liu S, Zhou Y, Wang X,et al. Biomass fuels are the probable risk factor for chronic obstructive pulmonary disease in rural South China. Thorax, 2007,62:889-897.
9Wong TW, Tam WS, Yu TS, et al. Associations between daily mortalities from respiratory and cardiovascular diseases and air pollution in Hong Kong, China. Oecup Environ Med, 2002,59:30-35.
10Kan H, Chen B. Air pollution and daily mortality in Shanghai:a time series study. Arch Environ Health, 2003, 58:360-367.
